GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (NAS:GRFS) » Definitions » Cyclically Adjusted PS Ratio

Grifols (Grifols) Cyclically Adjusted PS Ratio : 1.12 (As of Apr. 29, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Grifols Cyclically Adjusted PS Ratio?

As of today (2024-04-29), Grifols's current share price is $6.48. Grifols's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $5.79. Grifols's Cyclically Adjusted PS Ratio for today is 1.12.

The historical rank and industry rank for Grifols's Cyclically Adjusted PS Ratio or its related term are showing as below:

GRFS' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.97   Med: 3.55   Max: 6.43
Current: 1.08

During the past years, Grifols's highest Cyclically Adjusted PS Ratio was 6.43. The lowest was 0.97. And the median was 3.55.

GRFS's Cyclically Adjusted PS Ratio is ranked better than
69.15% of 739 companies
in the Drug Manufacturers industry
Industry Median: 2.09 vs GRFS: 1.08

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Grifols's adjusted revenue per share data for the three months ended in Dec. 2023 was $2.842. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $5.79 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Grifols Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Grifols's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols Cyclically Adjusted PS Ratio Chart

Grifols Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.91 4.18 - 1.51 2.00

Grifols Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.28 1.51 1.58 1.62 2.00

Competitive Comparison of Grifols's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Grifols's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grifols's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grifols's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Grifols's Cyclically Adjusted PS Ratio falls into.



Grifols Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Grifols's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=6.48/5.79
=1.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grifols's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Grifols's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.842/121.2698*121.2698
=2.842

Current CPI (Dec. 2023) = 121.2698.

Grifols Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201306 1.353 100.994 1.625
201309 1.321 100.597 1.592
201312 1.368 101.306 1.638
201403 1.597 100.139 1.934
201406 1.595 101.081 1.914
201409 1.541 100.441 1.861
201412 1.647 100.251 1.992
201503 1.454 99.474 1.773
201506 1.591 101.138 1.908
201509 1.556 99.559 1.895
201512 1.669 100.268 2.019
201603 1.535 98.638 1.887
201606 1.603 100.333 1.937
201609 1.664 99.737 2.023
201612 1.696 101.842 2.020
201703 1.662 100.896 1.998
201706 1.855 101.848 2.209
201709 1.799 101.524 2.149
201712 1.850 102.975 2.179
201803 1.845 102.122 2.191
201806 1.898 104.165 2.210
201809 1.966 103.818 2.296
201812 1.980 104.193 2.305
201903 1.943 103.488 2.277
201906 2.074 104.612 2.404
201909 2.116 103.905 2.470
201912 2.186 105.015 2.524
202003 2.089 103.469 2.448
202006 2.445 104.254 2.844
202009 2.317 103.521 2.714
202012 2.309 104.456 2.681
202103 2.064 104.857 2.387
202106 2.380 107.102 2.695
202112 0.000 111.298 0.000
202206 2.402 118.044 2.468
202209 2.248 117.221 2.326
202212 2.674 117.650 2.756
202306 2.657 120.278 2.679
202309 2.511 121.343 2.509
202312 2.842 121.270 2.842

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Grifols  (NAS:GRFS) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Grifols Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Grifols's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Grifols (Grifols) Business Description

Industry
Address
Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's biopharma business contributed 83% of sales in 2022. Grifols also has smaller segments including diagnostics and biosupplies. Diagnostics is roughly 10% of revenue following the Biotest acquisition.